Pharmaceutical Technology on MSN15h
FDA approves Gomekli as first neurofibromatosis drug for adults
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...
Study reveals potential therapeutic target for endometriosis
Endometriosis, a prevalent gynecological condition, is characterized by the growth of endometrial-like tissues outside the ...